Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eur Rev Med Pharmacol Sci ; 25(1): 390-396, 2021 01.
Article in English | MEDLINE | ID: mdl-33506928

ABSTRACT

OBJECTIVE: For safe implementation and broader application of fecal microbiota transplantation (FMT), quality controlled stool banking is a must. Establishing a stool bank is a complex, time-consuming, and expensive process, making it a real challenge in an Eastern European country. We aimed to establish the first stool bank in Eastern Europe - in Bulgaria. SUBJECTS AND METHODS: A multidisciplinary team of gastroenterologists, microbiologists, infectionists, and geneticists was set up. We used a questionnaire based on the First European FMT Consensus in order to recruit possible stool donors. Laboratory blood and stool tests were performed on all potential donors. RESULTS: Between October 2018 and April 2019, 112 donor volunteers completed a questionnaire; 70 (62.5%) were excluded, mainly because of age above 50, an unhealthy BMI, and risk behavior. Fourty-two (37.5%) donor candidates were invited for laboratory testing of blood and feces, of which 12 (28.6%) passed this screening. Of 12 donors, 4 (33%) failed at the following screening test, which is performed every 3-6 months. Finally, 8 (7.14%) active donors were enrolled. Ten successful FMTs were performed on patients with recurrent Clostridium difficile infection. CONCLUSIONS: Even though we found many healthy volunteers, only a low percentage (7.14%) of them were suitable to become feces donors. Establishing a stool bank in an Eastern European country is essential for making FMT safe and more popular as a treatment method, finding further implementation and regulation of FMT and supporting physicians offering this treatment to their patients.


Subject(s)
Enterocolitis, Pseudomembranous/therapy , Fecal Microbiota Transplantation , Adult , Aged , Bulgaria , Colonoscopy , Europe , Gastrointestinal Microbiome , Humans , Middle Aged , Surveys and Questionnaires , Young Adult
2.
Eur Arch Psychiatry Clin Neurosci ; 271(6): 1017-1025, 2021 Sep.
Article in English | MEDLINE | ID: mdl-32270290

ABSTRACT

Quality indicators are vital for monitoring the transformation of institution-based mental health services towards the provision of person-centered mental healthcare. While several mental healthcare quality indicators have been identified as relevant and valid, their actual usability and utility for routine monitoring healthcare quality over time is significantly determined by the availability and trustworthiness of the underlying data. In this feasibility study, quality indicators that have been systematically identified for use in the Danube region countries of Bulgaria, the Czech Republic, Hungary, and Serbia were measured on the basis of existing mental healthcare data in the four countries. Data were collected retrospectively by means of the best available, most standardized, trustworthy, and up-to-date data in each country. Out of 21 proposed quality indicators, 18 could be measured in Hungary, 17 could be measured in Bulgaria and in the Czech Republic, and 8 could be measured in Serbia. The results demonstrate that a majority of quality indicators can be measured in most of the countries by means of already existing data, thereby demonstrating the feasibility of quality measurement and regular quality monitoring. However, data availability and usability are scattered across countries and care sectors, which leads to variations in the quality of the quality indicators themselves. Making the planning and outputs of national mental healthcare reforms more transparent and evidence-based requires (trans-)national standardization of healthcare quality data, their routine availability and standardized assessment, and the regular reporting of quality indicators.


Subject(s)
Mental Disorders , Mental Health Services , Quality Indicators, Health Care , Europe , Feasibility Studies , Humans , Mental Disorders/therapy , Pilot Projects , Retrospective Studies
3.
Eur Rev Med Pharmacol Sci ; 24(1): 315-322, 2020 01.
Article in English | MEDLINE | ID: mdl-31957845

ABSTRACT

OBJECTIVE: To study gut barrier function in patients with liver cirrhosis (LC) by evaluating the intestinal permeability (IP) and its relationship with the severity and etiology of the disease. PATIENTS AND METHODS: The study included 31 patients with LC and 25 healthy controls. Child-Pugh score was used for evaluation of the LC severity. IP was assessed by the rise in levels of iohexol, which was administered orally (25 mL, 350 mg/mL) 2 h after breakfast. Three and six hours later serum (SIC mg/L) and urine (UIC g/mol) iohexol concentrations were determined by a validated HPLC-UV technique. RESULTS: Patients with LC had significantly higher mean SIC value compared with control group at 3 h (2.05 ± 1.67 vs. 1.25 ± 1.41 mg/L, p=0.021, as well as at 6 h (2.20 ± 2.65 vs. 1.11 ± 1.06 mg/L, p=0.001) after ingestion. No significant difference was found in mean SIC value of patients at 3 and 6 h. 23% of the patients had an increased IP. The mean iohexol urine recovery of patients was similar to that of the controls both at 3 h and at 6 h. Mean SIC values were significantly higher in patients with advanced Child C class than in healthy controls or the subgroup with Child B class, both at 3 h (2.54 ± 1.95 mg/L vs. 1.11 ± 1.06 mg/L, p=0.007) or (2.57 ± 1.85 mg/L vs. 1.35±1.32 mg/L, p=0.005) and at 6 h (2.57 ± 1.85 mg/L vs. 1.25 ± 1.40 mg/L, p=0.002) or 2.54 ± 1.95 mg/L vs. 1.07 ± 0.35 mg/L, p=0.02). Cirrhotic patients with ascites had significantly higher SIC in comparison with the controls, both at 3 h (2.31 ± 1.74 vs. 1.25 ± 1.41 mg/, p=0.009) and at 6 h (2.20 ± 1.87 vs. 1.11 ± 1.06 mg/l, p=0.007). In the subgroup of patients with alcoholic LC, the mean SIC values at 3 and 6 h (2.29 ± 1.80, 2.33 ± 1.85 mg/L, respectively) were significantly higher (p= 0.016, p=0.003) compared to the control group (1.25 ± 1.41, 1.11 ± 1.06 mg/L, respectively). CONCLUSIONS: Increased IP is found in 23% of cirrhotic patients. Permeability alterations are significantly more pronounced in patients with advanced LC with the presence of ascites and in those with alcoholic etiology.


Subject(s)
Intestinal Diseases/metabolism , Iohexol/analysis , Liver Cirrhosis/metabolism , Adult , Aged , Female , Healthy Volunteers , Humans , Intestinal Diseases/blood , Intestinal Diseases/urine , Liver Cirrhosis/blood , Liver Cirrhosis/urine , Male , Middle Aged , Permeability
4.
Eur Rev Med Pharmacol Sci ; 23(4): 1661-1667, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30840290

ABSTRACT

OBJECTIVE: We aimed to assess the preoperative rectal cancer angiogenesis with Endorectal Power Doppler Ultrasonography by using the Power Doppler Vascularity Index (PDVI) calculated by imaging analysis software, and to compare it with the microvessel density (MVD) in surgical specimens PATIENTS AND METHODS: This study included 110 patients (39 females; mean age 61.5 years) with rectal cancer. Immunohistochemical staining of surgical specimens with anti-CD-31 antibody was used for MVD evaluation. The PDVI of each tumor was calculated using Endorectal Power Doppler with computer-assisted quantification of colour pixels. RESULTS: Mean MVD - 163 ± 69 microvessels/mm2 (50-328) was used as a cutoff point, differentiating two groups of tumors with high (> 160 mm2) and low (≤ 160 mm2) angiogenic activity. Mean PDVI of 8.9 ± 6.0% (0-27.3) was used as a cutoff point, dividing two groups of tumors with high (> 8%) and low (≤ 8%) PDVI. The MVD and the PDVI showed a good positive correlation (r = 0.438, p = 0.002). Patients with low PDVI had 25 months longer overall survival (p < 0.05) than patients with high PDVI. Patients with low MVD had 36 months longer survival (p < 0.05). CONCLUSIONS: Endorectal Power Doppler Ultrasonography is a reliable and noninvasive method for assessment of the extent of rectal cancer angiogenesis. Tumor angiogenesis assessed by the PDVI correlated with histological MVD determination and could predict survival rates. Endorectal Power Doppler examination is a useful and reproducible method for in vivo preoperative quantitative assessment of tumor vascularization.


Subject(s)
Neovascularization, Pathologic/pathology , Rectal Neoplasms/pathology , Ultrasonography, Doppler , Endosonography , Female , Humans , Middle Aged , Neovascularization, Pathologic/surgery , Prospective Studies , Rectal Neoplasms/surgery , Software
5.
Eur Rev Med Pharmacol Sci ; 23(2): 788-794, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30720187

ABSTRACT

OBJECTIVE: In this study, we aimed to evaluate the role of serum trefoil factor 3 (TFF3) as a biomarker of disease activity in patients with inflammatory bowel disease (IBD) and to compare TFF3 values with those of fecal calprotectin (FC). PATIENTS AND METHODS: 128 patients with IBD were divided into four groups: 1) active ulcerative colitis (UC); 2) quiescent UC; 3) active Crohn's disease (CD); 4) quiescent CD. The serum levels of TFF3 and FC levels were assessed in all patients and 16 controls. RESULTS: Patients with active UC had higher TFF3 levels than those with quiescent UC (p<0.001), those with active (p<0.001) or quiescent CD (p<0.001) and controls (p <0.001). We found a correlation between TFF3 and FC values in patients with active (r = 0.478, p = 0.006) and quiescent UC (r=0.528, p=0.002). TFF3 levels correlated with endoscopic activity in UC (evaluated by UC Endoscopic Index of Severity - UCEIS) (r=0.662, p<0.001). CONCLUSIONS: Serum TFF3 is able to identify patients with active UC. It could be used as a marker to predict disease activity in patients with UC.


Subject(s)
Colitis, Ulcerative/diagnosis , Crohn Disease/diagnosis , Trefoil Factor-3/blood , Adolescent , Adult , Biomarkers/blood , Colitis, Ulcerative/blood , Colitis, Ulcerative/immunology , Colitis, Ulcerative/pathology , Colon/diagnostic imaging , Colon/immunology , Colon/pathology , Colonoscopy , Crohn Disease/blood , Diagnosis, Differential , Feces/chemistry , Female , Humans , Intestinal Mucosa/diagnostic imaging , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Leukocyte L1 Antigen Complex/analysis , Male , Middle Aged , ROC Curve , Severity of Illness Index , Young Adult
6.
Eksp Med Morfol ; 16(1): 6-11, 1977.
Article in Bulgarian | MEDLINE | ID: mdl-880915

ABSTRACT

The authors examined age peculiarities in the microcirculation bed of the intestinal mucosa in 20 individuals, aged from 0 to 83 years. The vessels were manifested by injection with Indian ink-gelatine mass. There was also complication of their angioarthitectonics parallel to the age and progressive thickening of glandular layer and enlargement and clongation of the villi. The arterial sources were increased and varified. Villus-capillary nest was changed in vertical direction. Togethe with this the outflow venous system was complicated as over the basal plexus a second venous plexus was formed-over the basis of the villi. The mucosa was enriched with arterio-venous anastomosis. Maximal development of the microcirculatory system was found at the end of the third decade, after which their reduction begins. This process was more manifested after the sixth decade, when the blood vessels were folded and received uneven constructions and dilatations, and then the capillary nest is rearranged and simplified.


Subject(s)
Intestinal Mucosa/blood supply , Microcirculation , Adolescent , Adult , Age Factors , Aged , Arteriovenous Anastomosis , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...